Minnesota SF 2888: Minnesota prescription monitoring program reporting requirements and immunity from liability modification

Status: Joint rule 2.03, referred to Rules and Administration (as of 2023-03-22)

State: Minnesota · Session: 2023-2024 · Bill: SF 2888

Subjects: Drugs and Medicine, Government-State, Health and Health Department

Sponsors: Wiklund, Mann

View Minnesota SF 2888 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.